Literature DB >> 15717111

[Patients with epilepsy and anxiety disorders. Diagnosis and treatment].

S Beyenburg1, D Schmidt.   

Abstract

Up to 50-60% of patients with epilepsy may develop psychiatric complications, in particular depression, anxiety, and psychotic disorders. Although this comorbidity has received a great deal of attention in recent years, the anxiety spectrum of psychiatric disturbances in epilepsy patients has not been extensively studied, although this comorbidity has a significant effect on the medical management and quality of life. The etiology is multifactorial, including neurobiological and shared pathophysiological mechanisms as well as psychosocial and iatrogenic factors (e.g., influence of antiepileptic drugs, epilepsy surgery). Despite the high prevalence of comorbid anxiety in epilepsy, very little is known about optimal treatment strategies. This article reviews the complex interrelationships between anxiety disorders and epilepsy from a clinical point of view. The evaluation of anxiety relative to ictal, peri-ictal, and postictal states is described, and medical treatment options for anxiety disorders in patients with epilepsy are discussed, illustrating that their treatment extends far beyond seizure control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717111     DOI: 10.1007/s00115-004-1867-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  91 in total

1.  Psychiatric adverse events during vigabatrin therapy.

Authors:  D F Levinson; O Devinsky
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

Review 2.  Mood disorders in patients with epilepsy: epidemiology and management.

Authors:  Cynthia L Harden; Martin A Goldstein
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Psychiatric disorders in candidates for surgery for epilepsy.

Authors:  R Manchanda; B Schaefer; R S McLachlan; W T Blume; S Wiebe; J P Girvin; A Parrent; P A Derry
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 4.  Pregabalin: a new anxiolytic.

Authors:  Bianca A Lauria-Horner; Robert B Pohl
Journal:  Expert Opin Investig Drugs       Date:  2003-04       Impact factor: 6.206

Review 5.  Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.

Authors:  F Pisani; E Spina; G Oteri
Journal:  Epilepsia       Date:  1999       Impact factor: 5.864

6.  Epilepsy and Anxiety.

Authors:  Martin Adam Goldstein; Cynthia L. Harden
Journal:  Epilepsy Behav       Date:  2000-08       Impact factor: 2.937

7.  Depression and Anxiety in Patients with Epilepsy.

Authors:  Ada Piazzini; Maria Paola Canevini; Giovanna Maggiori; Raffaele Canger
Journal:  Epilepsy Behav       Date:  2001-10       Impact factor: 2.937

Review 8.  The impact of mood disorders in neurological diseases: should neurologists be concerned?

Authors:  Andres M Kanner; John J Barry
Journal:  Epilepsy Behav       Date:  2003-10       Impact factor: 2.937

9.  Fear of seizures: an investigation and treatment.

Authors:  I Newsom-Davis; L H Goldstein; D Fitzpatrick
Journal:  Seizure       Date:  1998-04       Impact factor: 3.184

10.  Focal paroxysmal EEG changes during atypical panic attacks.

Authors:  J B Weilburg; S Schachter; G S Sachs; J Worth; M H Pollack; J R Ives; D L Schomer
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1993       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.